Dr.T.Venkatachalam Professor of Anaesthesiology Madras Medical College, Chennai.

Slides:



Advertisements
Similar presentations
RET 1024 Introduction to Respiratory Therapy
Advertisements

A Look Into Congestive Heart Failure By Tim Gault.
Congestive Heart Failure
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
Congestive heart failure
Prof. Dr. Bahaa Ewiss Professor of Ansthesia & Intensive Care Unit Ain Shams university.
Cardioanaesthesia. Coronary artery disease O 2 delivery Coronary blood flow = directly related to coronary perfusion pressure (CPP) CPP = aortic diastolic.
CVS Changes During Pregnancy PARAMETERDIRECTIONTIME COURSE Heart rate ↑ 1 st and 2 nd trimester (TM) Blood pressure ↓ Fall in TM 1 and 2, returns to baseline.
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Bio-Med 350 Normal Heart Function and Congestive Heart Failure.
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
Heart Failure Whistle Stop Talks No 1 HFrEF and HFpEF Definitions for Diagnosis Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Dr. Meg-angela Christi M. Amores
Hemodynamic Monitoring By Nancy Jenkins RN,MSN. What is Hemodynamic Monitoring? It is measuring the pressures in the heart.
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
HEART FAILURE PROF. DR. MUHAMMAD AKBAR CHAUDHRY M.R.C.P.(U.K) F.R.C.P.(E) F.R.C.P.(LONDON) F.A.C.C. DESIGNED AT A.V. DEPTT F.J.M.C. BY RABIA KAZMI.
Ventricular Diastolic Filling and Function
Aetiology * MVP { Myxomatous mv },commonest in developed world *Damage to the cusps : _RVD _ IE _ Congenital Cleft MV *Damage to chordae : _RVD.
In the Name of Allah the Most Beneficent and Merciful C ardiomyopathies Prof. Dr. Muhammad Akbar Chaudhry M.R.C.P.( UK ), F.R.C.P.( E ) F.R.C.P. ( LONDON.
Lecture 6b 10 Feb Congestive heart failure Class activity-what is the best approach to avoiding CHF.
Common Clinical Scenarios *Younger people *Younger people _Functional murmur vs _Functional murmur vs _ MVP vs _ MVP vs _ AS _ AS *Older people _Aortic.
Shannen Whiddon.  Cardiac tamponade is a condition in which cardiac filling is impeded by an external force.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
PREGNANCY AND HEART FAILURE PROF.DR. MUHAMMAD AKBAR CHAUDHARY M.R.C.P. (U.K.) F.R.C.P. (E) F.R.C.P. (LONDON) F.A.C.C Designed At A.V. Dept. F.J.M.C. By.
Outline The critical physiological changes of pregnancy. The critical physiological changes of pregnancy. Predictors of cardiac events during pregnancy.
HEART FAILURE Prevalence increasing in our ageing population Incidence doubles with each decade between 40 and 80 At any age more common in men than women.
CONCEPTS OF NORMAL HEMODYNAMICS AND SHOCK
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Causes Myocardial dysfunction eg IHD, CM Volume overload eg AR, MR Obstruction eg AS, HCM Diastolic dysfunction eg Constriction Mechanical problems eg.
Mitral Valve Disease Prof JD Marx UFS January 2006.
CARDIAC DISEASES IN PREGNANCY DR. RAZAQ MASHA,FRCOG Assistant Professor & Consultant Department of Obstetrics & Gynaecology.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Causes of valve disease Valve regurgitation * Congenital *Acute rheumatic carditis *Chronic rhe. Carditis * I E *Syphlitic aortitis *Dilated Valve.
Drug Therapy Heart Failure by Pat Woodbery, MSN, ARNP.
CARDIAC DISEASE IN PREGNANCY. Physiologic Changes of Pregnancy Blood volume and cardiac output rise in pregnancy to a peak that is 150% of normal by 24.
Rheumatic Heart Disease Definition: streptococcal infection. children Pathology: - Anti-gen antibody reaction mediate inflammation. - * Clinical.
Medical Disease in Pregnancy Cardiovascular Disease Cullen Archer, MD Department of Obstetrics and Gynecology.
Complication during pregnancy and its nursing management: - Pregnancy induces hypertension. Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture.
Heart failure Dr Rafat Mosalli. Objectives Definition Definition Pathophysiology Pathophysiology Age specific Causes Age specific Causes Clinical pictures.
Cardiac Failure Richard Price Richard Price Consultant, Intensive Care, RAH. Consultant, Intensive Care, RAH.
Frank-Starling Mechanism
HEART DISEASE IN PREGNANCY. The incidence of cardiac lesion is less than 1% among hospital deliveries. The commonest cardiac lesion is of rheumatic origin.
Nursing and heart failure
Adult Medical-Surgical Nursing
Heart Failure Heart is unable to pump sufficient blood to meet the needs of the body. It is key symptoms are dyspnea, fatigue, fluid retention. HF is.
Management of Heart Disease in Pregnancy.  It is estimated that 1% to 3% of women either have cardiac disease entering pregnancy or are diagnosed with.
Pt’s treated with B-blockers post infarction are seen to have a significant reduction in re-infraction.
HEART FAILURE Jamil Mayet Consultant Cardiologist.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
– Dr. J. Satish Kumar, MD, Department of Basic & Medical Sciences, AUST General Medicine CVS Name:________________________________________ Congestive Heart.
Internal Medicine Workshop Series Laos September /October 2009
Exercise Management Chronic Heart Failure Chapter 12.
 By the end of this lecture the students are expected to:  Explain how cardiac contractility affect stroke volume.  Calculate CO using Fick’s principle.
Cardiac diseases in pregnancy. These women should be fully assessed before pregnancy and the maternal and fetal risks carefully explained. Cardiologist.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
INFANTS OF DIABETIC MOTHERS MUHAMMAD ALI Cardiology Division Department of Child Health University of Sumatera Utara.
Congestive Heart Failure MUHAMMAD ALI PEDIATRIC CARDIOLOGY DIVISION.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy in Patients With Pre-Existing Cardiomyopathies.
Dr.H-Kayalha Anesthesiologist Aortic regurgitation results from failure of aortic leaflet coaptation caused by disease of the aortic leaflets or of.
Heart Faliure Prof . El Sayed Abdel Fattah Eid
Heart Failure in Women Dr. Jennifer Haythe
Dr. M. A. Sofi MD; FRCP (London); FRCPEdin; FRCSEdin
Cardiothoracic Surgery
Deep Vein Thrombosis & Pulmonary Embolism
Myocarditis.
In the name of God. In the name of God Peripartum cardiomyopathy Dr. Minoo Movahedi.
Congestive heart failure
Nursing Care of Patients with Heart Failure
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Presentation transcript:

Dr.T.Venkatachalam Professor of Anaesthesiology Madras Medical College, Chennai

 Peripartum cardiomyopathy is defined as the onset of acute heart failure without demonstrable cause in the last trimester of pregnancy or within the first 5 months after delivery.

 A form of Dilated Cardiomyopathy  Left ventricular systolic dysfunction  Results in signs and symptoms of heart failure  Often unrecognized, as symptoms of normal pregnancy commonly mimic those of mild heart failure.

1.Development of Cardiac failure in the last month of pregnancy or within 5 month after delivery 2. Absence of an identifiable cause for the cardiac failure. 3.Absence of recognizable heart disease prior to the last month of pregnancy. 4.Left ventricular systolic dysfunction demonstrated by classic Echo Cardio Graphic criteria such as depressed shortening fraction or ejection fraction. The National Heart, Lung and Blood Institute and the Office of rare diseases (1997)

 The incidence in the west ranges from 1 in 4000 deliveries  Sixty percent present within the first 2 months postpartum  Up to 7% may present in the last trimester of pregnancy.  Geographic variations exist with a higher incidence reported in areas of Africa because of malnutrition and local customs in the puerperium

Still unknown.  -nutritional deficiencies  -small vessel coronary artery abnormality  -hormonal effects  -toxemia  -maternal immunologic response to fetal antigen or  -myocarditis

 -maternal age greater than 30 yr  -multiparous or eclamptic patients  - twinning  - racial origin (black)  - hypertension and  - nutritional deficiencies  In majority of cases there is no family history

Symptoms of worsening cardiac failure like:  -dyspnoea on exertion  -fatigue  -ankle oedema  -embolic phenomena  -atypical chest pains and  -haemoptysis.  Many of above symptoms may occur even in normal pregnancy and can be mistaken for a diseased state.

 -evidence of a raised CVP  -tachycardia  -cardiomegaly with a gallop rhythm (S3)  -mitral regurgitation  -pulmonary crackles and  -peripheral oedema.

On auscultation of the heart:  loud first heart sound  exaggerated splitting  mid systolic murmur and  continuous venous hum  These physical signs may confuse and there could be mistakes in the form of over diagnosis or disregarding of heart disease.

Chest radiograph:  cardiomegaly with pulmonary oedema  pulmonary venous congestion. The ElectroCardioGram:  non­specific ST and T wave changes  atrial or ventricular arrhythmias and  conduction defects.

 may reveal enlargement of all four chambers with marked reduction in left ventricular systolic function  small to moderate pericardial effusion and  mitral, tricuspid and pulmonary regurgitation  Ventricular wall motion, ejection fraction and cardiac output are decreased and  pulmonary wedge pressure is increased.

 The clinical presentation and hemodynamic features in PPCM are indistinguishable from those of other forms of dilated cardiomyopathy.  In the absence of any cardiac symptoms, one of the early indications about this condition is revealed during evaluation of the fetus with a fetal monitor and ultrasound

 Fetal growth is dependent on good blood flow to the uterus and placenta  An insufficient blood flow means decreased oxygenation resulting in slowed growth  This should prompt further investigation to discover heart disease.

50-60% patients show complete or near complete recovery within the first 6 months postpartum In others, either continued clinical deterioration leading to early death or persistent left ventricular dysfunction and chronic heart failure results There is an initial high risk period with mortality of 25-50% in the first 3 months postpartum. Patients with persistent cardiomegaly at 6 months have a reported mortality of 85% at 5 years.

 Subsequent pregnancies in women with PPCM are often associated with relapses and high risk for maternal morbidity and mortality.  should be discouraged in women with PPCM who have persistent cardiac dysfunction.

Vigorous treatment of acute heart failure.  Oxygen, diuretics, digoxin and vasodilators  Use of ACE inhibitors in early pregnancy should be avoided as it has teratogenic effects on fetus

 Anticoagulant therapy is recommended because of high incidence of thrombo embolic events in PPCM  Patient on oral anticoagulants require change to parenteral anticoagulants with short half life  Dose adjusted according to the PTT which may be discontinued before delivery.  After delivery Warfarin may be used

 Since the disease may be reversible, the temporary use of Intra Aortic Balloon Pump or LV assist device may help to stabilize the patient’s condition pending improvement.

 Many patients with PPCM show evidence of myocarditis in biopsy specimens.  Dobutamine stress echocardiography - for evaluating contractile reserve in women with recovered systolic function who are contemplating further pregnancies.

 Autopsy shows cardiac enlargement, often with mural thrombi along with histological evidence of myocardial degeneration and fibrosis.

Similar for any patient with heart failure presenting for caesarian section regardless of etiology  Hemodynamic goals include: 1. Maintenance of normal to low heart rate to decrease oxygen demand 2. Prevention of large swings in blood pressure. These goals can be achieved by giving either general or regional anesthesia

 During GA important factors to keep in mind are: 1. Volatile agents that decrease LV contractility without dramatic vasodilatation is desirable. 2. Avoid agents that decease preload and after load. eg. hypovolemia, nitroglycerine, nitroprusside 3. Avoid agents that directly or indirectly increase heart rate and contractility like Pancuronium, atropine, epinephrine, ephedrine..

4. Replace Blood loss promptly. 5. Hypotension better treated with volume expansion and pure alpha adrenergic agonist. 6. Remember that insertion of CVP / PAC may induce atrial or ventricular dysarrhytmias

 IV and Inhalational agents Cardiac depression  High dose Narcotics – Need for post op ventilation for both mother and child. -There is an increased risk of gastric aspiration.  The management of a failed intubation may become difficult by the longer acting nature of these drugs with mask ventilation and if associated with obesity.

 The consideration for in these patients are similar to those with other causes of heart failure.  Subarachnoid block may better be avoided in these patients because of sudden onset of hemodynamic instability.

Epidural anaesthesia -better choice  incremental doses  with opioids. May improve myocardial performance and the cardiac output by decreasing the systemic vascular resistance, thus reducing the after load on the left ventricle without impairing contractility

 Pulmonary Artery catheter can guide fluid and inotrope requirements  Preloading to be avoided in these patients  Small bolus doses of 0.5% Bupivacaine or 2.0% Xylocaine (10 to 12 ml in L2 to L4) along with fentanyl up to 40 µg may be preferred.

 Depends on the preoperative signs and symptoms.  In asymptomatic patients, a central venous catheter is adequate with non invasive BP monitoring.  In symptomatic patients or with echo findings of left ventricular dysfunction, a PA catheter and an arterial line if available will be useful.

 Oxytocin infusion is preferable  As infusion it will not produce sudden vasodilatation and hypotension.  It also helps to decrease the after load maintaining the hemodynamic stability

 It is better to monitor these patients in an ICU for hemodynamic stabilization.  It may worsen due to retention of water due to ant diuretic effect of Oxytocin  Re absorption of third space fluid after 48 hrs of the caesarian section.  The above factors increase the preload, worsening the patient’s condition.

 May develop a reduction in the left ventricular systolic function during subsequent pregnancies  This reduction would be greater in those with persistent left ventricular dysfunction at the start of the pregnancies.  Symptoms of heart disease develop in about 20% of women whose systolic function is normal at the start of the subsequent pregnancy and in almost half of the women who have persistent left ventricular dysfunction

 The out come is highly variable.  Some develop persistent disease while some return to normal state slowly.  These patients has a better survival rate than other types of cardiomyopathy.

 PPCM mimics changes occurring in normal pregnancy  Fetal growth retardation may point towards this condition  Treat like any other cardiac failure along with anti coagulant therapy  Epidural anaesthesia is preferable and continue monitoring in an ICU  Advice against subsequent pregnancies.